Elicio Therapeutics Marks Significant Financial Turnaround and Pivotal Clinical Advances in Latest Quarter A Breakthrough on the Horizon: Daraxonrasib Offers New Hope for Pancreatic Cancer Patients A Glimmer of Hope: Candel Therapeutics Reveals Promising Long-Term Data for Pancreatic Cancer Treatment